This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Haffner, S. M. Search for Related Content PubMed PubMed Citation Articles by Haffner, S. M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Diabetes

The Importance of Hyperglycemia in the Nonfasting State to the Development of Cardiovascular Disease

Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78284-7873

I. Introduction

II. Correlation Between Hyperglycemia and CVD

A. Type 2 diabetes

B. Elevated glucose concentrations in the nondiabetic range

C. Atherosclerosis in subjects with asymptomatic hyperglycemia

III. Causal Relationship of Postprandial Hyperglycemia to CVD

A. Direct effects of hyperglycemia

B. Insufficient insulin production

C. Insulin resistance and hyperinsulinemia

D. Association with risk factors for CVD

IV. Therapeutic Interventions for Type 2 Diabetes

A. Insulin therapy

B. Sulfonylureas

C. Biguanides

D. Acarbose

V. Studies to Prevent Type 2 Diabetes

VI. Conclusions

This article has been cited by other articles:

				R. Muniyappa, M. Montagnani, K. K. Koh, and M. J. Quon Cardiovascular Actions of Insulin Endocr. Rev., August 1, 2007; 28(5): 463 - 491. [Abstract] [Full Text] [PDF]

				P. H. McNulty, M. A. Tulli, B. J. Robertson, V. Lendel, L. A. Harach, S. Scott, and J. P. Boehmer Effect of simulated postprandial hyperglycemia on coronary blood flow in cardiac transplant recipients Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H103 - H108. [Abstract] [Full Text] [PDF]

				M. E. Tushuizen, R. Nieuwland, C. Rustemeijer, B. E. Hensgens, A. Sturk, R. J. Heine, and M. Diamant Elevated Endothelial Microparticles Following Consecutive Meals Are Associated With Vascular Endothelial Dysfunction in Type 2 Diabetes Diabetes Care, March 1, 2007; 30(3): 728 - 730. [Full Text] [PDF]

				S. Ghosh, Y. Lu, A. Katz, Y. Hu, and R. Li Tumor suppressor BRCA1 inhibits a breast cancer-associated promoter of the aromatase gene (CYP19) in human adipose stromal cells Am J Physiol Endocrinol Metab, January 1, 2007; 292(1): E246 - E252. [Abstract] [Full Text] [PDF]

				I. W Campbell The role of metformin and pioglitazone in early combination treatment of type 2 diabetes mellitus The British Journal of Diabetes & Vascular Disease, September 1, 2006; 6(5): 207 - 215. [Abstract] [PDF]

				F. Cavalot, A. Petrelli, M. Traversa, K. Bonomo, E. Fiora, M. Conti, G. Anfossi, G. Costa, and M. Trovati Postprandial Blood Glucose Is a Stronger Predictor of Cardiovascular Events Than Fasting Blood Glucose in Type 2 Diabetes Mellitus, Particularly in Women: Lessons from the San Luigi Gonzaga Diabetes Study J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 813 - 819. [Abstract] [Full Text] [PDF]

				Y. Kataoka, S. Yasuda, I. Morii, Y. Otsuka, A. Kawamura, and S. Miyazaki Quantitative Coronary Angiographic Studies of Patients With Angina Pectoris and Impaired Glucose Tolerance Diabetes Care, September 1, 2005; 28(9): 2217 - 2222. [Abstract] [Full Text] [PDF]

				H. Taegtmeyer Glucose for the Heart: Too Much of a Good Thing? J. Am. Coll. Cardiol., July 5, 2005; 46(1): 49 - 50. [Full Text] [PDF]

				A. Gallo, G. Ceolotto, P. Pinton, E. Iori, E. Murphy, G. A. Rutter, R. Rizzuto, A. Semplicini, and A. Avogaro Metformin Prevents Glucose-Induced Protein Kinase C-{beta}2 Activation in Human Umbilical Vein Endothelial Cells Through an Antioxidant Mechanism Diabetes, April 1, 2005; 54(4): 1123 - 1131. [Abstract] [Full Text] [PDF]

				M E Tushuizen, M Diamant, and R J Heine Postprandial dysmetabolism and cardiovascular disease in type 2 diabetes Postgrad. Med. J., January 1, 2005; 81(951): 1 - 6. [Abstract] [Full Text] [PDF]

				C. Meyer, H. J. Woerle, J. M. Dostou, S. L. Welle, and J. E. Gerich Abnormal renal, hepatic, and muscle glucose metabolism following glucose ingestion in type 2 diabetes Am J Physiol Endocrinol Metab, December 1, 2004; 287(6): E1049 - E1056. [Abstract] [Full Text] [PDF]

				A. Festa, R. D'Agostino Jr., A. J.G. Hanley, A. J. Karter, M. F. Saad, and S. M. Haffner Differences in Insulin Resistance in Nondiabetic Subjects With Isolated Impaired Glucose Tolerance or Isolated Impaired Fasting Glucose Diabetes, June 1, 2004; 53(6): 1549 - 1555. [Abstract] [Full Text] [PDF]

				A. S. Reed, N. Charkoudian, A. Vella, P. Shah, R. A. Rizza, and M. J. Joyner Forearm vascular control during acute hyperglycemia in healthy humans Am J Physiol Endocrinol Metab, March 1, 2004; 286(3): E472 - E480. [Abstract] [Full Text]

				V. Fonseca, C. Desouza, S. Asnani, and I. Jialal Nontraditional Risk Factors for Cardiovascular Disease in Diabetes Endocr. Rev., February 1, 2004; 25(1): 153 - 175. [Abstract] [Full Text] [PDF]

				D. K. Plante and J. L. Nadler Diabetes and Vascular Disease Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2003; 7(3): 295 - 310. [Abstract] [PDF]

				J. E. Gerich Clinical Significance, Pathogenesis, and Management of Postprandial Hyperglycemia Arch Intern Med, June 9, 2003; 163(11): 1306 - 1316. [Abstract] [Full Text] [PDF]

				H. J. Woerle, C. Meyer, J. M. Dostou, N. R. Gosmanov, N. Islam, E. Popa, S. D. Wittlin, S. L. Welle, and J. E. Gerich Pathways for glucose disposal after meal ingestion in humans Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E716 - E725. [Abstract] [Full Text] [PDF]

				A. J Krentz, R. Mani, and C. P Shearman Review: Peripheral arterial disease in diabetes: time for a co-ordinated approach to management The British Journal of Diabetes & Vascular Disease, March 1, 2003; 3(2): 92 - 96. [Abstract] [PDF]

				N. N. Wahab, E. A. Cowden, N. J. Pearce, M. J. Gardner, H. Merry, J. L. Cox, and ICONS Investigators Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J. Am. Coll. Cardiol., November 20, 2002; 40(10): 1748 - 1754. [Abstract] [Full Text] [PDF]

				N. Charkoudian, A. Vella, A. S. Reed, C. T. Minson, P. Shah, R. A. Rizza, and M. J. Joyner Cutaneous vascular function during acute hyperglycemia in healthy young adults J Appl Physiol, October 1, 2002; 93(4): 1243 - 1250. [Abstract] [Full Text] [PDF]

				M.J. Sampson, I.R. Davies, J.C. Brown, K. Ivory, and D.A. Hughes Monocyte and Neutrophil Adhesion Molecule Expression During Acute Hyperglycemia and After Antioxidant Treatment in Type 2 Diabetes and Control Patients Arterioscler. Thromb. Vasc. Biol., July 1, 2002; 22(7): 1187 - 1193. [Abstract] [Full Text] [PDF]

				C. Parkinson, W. M. Drake, M. E. Roberts, K. Meeran, G. M. Besser, and P. J. Trainer A Comparison of the Effects of Pegvisomant and Octreotide on Glucose, Insulin, Gastrin, Cholecystokinin, and Pancreatic Polypeptide Responses to Oral Glucose and a Standard Mixed Meal J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1797 - 1804. [Abstract] [Full Text] [PDF]

				P. A. Watson, A. Nesterova, C. F. Burant, D. J. Klemm, and J. E.-B. Reusch Diabetes-related Changes in cAMP Response Element-binding Protein Content Enhance Smooth Muscle Cell Proliferation and Migration J. Biol. Chem., November 30, 2001; 276(49): 46142 - 46150. [Abstract] [Full Text] [PDF]

				G. Ceolotto, A. Gallo, M. Sartori, R. Valente, E. Baritono, A. Semplicini, and A. Avogaro Hyperglycemia Acutely Increases Monocyte Extracellular Signal-Regulated Kinase Activity in Vivo in Humans J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1301 - 1305. [Abstract] [Full Text]

				S. Uemura, H. Matsushita, W. Li, A. J. Glassford, T. Asagami, K.-H. Lee, D. G. Harrison, and P. S. Tsao Diabetes Mellitus Enhances Vascular Matrix Metalloproteinase Activity : Role of Oxidative Stress Circ. Res., June 22, 2001; 88(12): 1291 - 1298. [Abstract] [Full Text] [PDF]